Inactive Instrument
Guardion Health Sciences Inc Stock Nasdaq
Stocks
US40145Q2030
Pharmaceuticals
OTC Markets Traded| Market Cap | 4.35M 3.74M 3.52M 3.21M 6M 411M 6.02M 41.69M 16.11M 211M 16.32M 15.97M 671M | P/E 2022 |
-0.51x | P/E 2023 | 42.9x |
|---|---|---|---|---|---|
| Enterprise Value | -2.01M -1.73M -1.63M -1.49M -2.78M -190M -2.79M -19.3M -7.46M -97.48M -7.56M -7.39M -311M | EV / Sales 2022 |
-0.16x | EV / Sales 2023 | 0.04x |
| Free-Float |
98.7% | Yield 2022 * |
-
| Yield 2023 | - |
| 1 day | +24.84% |
| Manager | Title | Age | Since |
|---|---|---|---|
Mark Goldstone
CEO | Chief Executive Officer | 62 | 2024-10-17 |
| Corporate Secretary | 74 | - | |
Susan Klein
PRN | Corporate Officer/Principal | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 74 | 2020-06-30 | |
Mark Goldstone
BRD | Director/Board Member | 62 | 2015-05-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +24.84% | +22.50% | - | - | 4.35M | |
| -0.88% | -0.64% | +58.05% | +100.51% | 1,024B | |
| -1.15% | +3.53% | +54.25% | +71.99% | 663B | |
| -1.44% | +0.02% | +20.65% | +72.22% | 453B | |
| +0.25% | +1.99% | +31.21% | +38.06% | 349B | |
| -10.01% | -13.67% | +10.50% | +28.30% | 295B | |
| -0.47% | +0.17% | +0.10% | +10.47% | 253B | |
| -1.55% | +1.71% | +54.15% | +71.87% | 236B | |
| -0.34% | +1.17% | -14.30% | -56.12% | 206B | |
| -0.15% | +3.18% | +31.24% | +104.21% | 187B | |
| Average | +0.91% | +1.17% | +27.32% | +49.06% | 407.48B | |
| Weighted average by Cap. | -1.57% | +0.52% | +36.69% | +63.45% |
| 2022 | 2023 | |
|---|---|---|
| Net sales | 11.05M 9.5M 8.94M 8.16M 15.26M 1.05B 15.31M 106M 40.96M 535M 41.5M 40.59M 1.7B | 12.25M 10.53M 9.91M 9.04M 16.91M 1.16B 16.97M 117M 45.41M 593M 46M 44.99M 1.89B |
| Net income | -14.92M -12.83M -12.07M -11.02M -20.61M -1.41B -20.67M -143M -55.32M -723M -56.04M -54.81M -2.3B | 158K 136K 128K 117K 218K 14.95M 219K 1.52M 586K 7.65M 593K 581K 24.38M |
| Net Debt | -10.65M -9.16M -8.62M -7.86M -14.71M -1.01B -14.76M -102M -39.49M -516M -40M -39.13M -1.64B | -6.36M -5.47M -5.14M -4.7M -8.78M -601M -8.81M -60.99M -23.58M -308M -23.88M -23.36M -981M |
Employees
-
Sector
Pharmaceuticals
